To investigate whether pirfenidone effects seen in the Fra-2 TG mouse model of SSc-ILD may also be observed in another pulmonary fibrosis model, we investigated the pirfenidone response in a mouse model of bleomycin-induced lung fibrosis. This evidence concerns the gene FOSL2 and interstitial lung disease.